A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
about
Ketamine and other glutamate receptor modulators for depression in adultsBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewPharmacological approaches to the challenge of treatment-resistant depressionThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmNine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology reviewEmerging drugs for the treatment of anxietyInvestigating the mechanism(s) underlying switching between states in bipolar disorderR-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effectsThe neuroscience of depression: implications for assessment and intervention.Disclosing the potential impact of placebo controls in antidepressant trials.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.Glutamate NMDA receptor modulators for the treatment of depression: trials and tribulations.Investigational drugs in recent clinical trials for treatment-resistant depression.Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Ketamine - A Multifaceted Drug.Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart reviewComparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.The interactive effects of ketamine and magnesium upon depressive-like pathology.Depression: Ketamine steps out of the darknessSingle-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial).Mixed States in Bipolar Disorder: Etiology, Pathogenesis and TreatmentAdjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.Multistage drug effects of ketamine in the treatment of major depression.Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?The promise of ketamine for treatment-resistant depression: current evidence and future directions.Ketamine and international regulations.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review.Neuropathology of suicide: recent findings and future directions.The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs.Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review.Targeting glutamate signalling in depression: progress and prospects.
P2860
Q24186746-FB44CC09-EEBF-45B1-B497-3CFD5A0D09E1Q26782993-AA6C3EAE-30B3-404B-8389-E7565F04C51BQ26798241-93280035-D760-46CC-9ED0-2622AB77BA3BQ28066714-E9D9842E-8F87-4455-93CC-1B2F347222C6Q28067988-620A116C-B2B1-43EA-9921-A4A74918EBB9Q28083141-9412C8AB-866E-4B71-8867-FF52F952430CQ28084519-A0B1A801-C5BD-4921-804C-6C0CACD142C4Q28266846-112D7664-1E56-4773-9880-2EC7114255A0Q30399725-0EC28C0A-4997-4999-AE4E-7E4B92C82102Q30489955-9B833E49-B7A3-48B1-B715-51C2FCA61442Q30927398-56C00E13-E819-47BA-9DFF-94E5A023E68DQ30987882-C4B0C210-CC3E-40E9-AA73-54EC0E265456Q33693374-C7FED394-E841-4B03-AB42-0A1AEDAF58BBQ33747674-222253F4-6C1E-4A1D-978F-B8F3F33EB580Q34466310-1583945A-288C-4498-8037-F5AB16980EB7Q34549390-A77962D6-0CF6-49DE-9B18-BEC8EA71653FQ35547495-B6FCE516-0595-4376-9515-47B41B2C6D91Q36039428-18562AE5-6EBE-4E60-91AC-F164687372BDQ36176755-0F6F20B3-F8AD-4A31-BA81-6D7030C57510Q36236193-70DC5880-CDC9-4EEF-98DB-2A2E09297660Q36798980-095B9CA6-3FD8-4D68-B0E0-523D48BAD81EQ36852411-4A2E5063-8081-4D14-826C-6F3F81F27B3AQ37249086-34D1F09E-941F-48A3-9891-C2251E6FB89CQ37403546-2E1F9F6A-6972-4453-8A13-0F29366ED309Q37424333-F6A3A8E4-DC69-43C4-9BAE-C8B81D61BAB4Q37498103-BB36C876-7611-4032-BD8F-14974A3A2560Q37633075-543C8310-2901-4819-93F7-BF5DA39D62C1Q37644483-2AA5EAB8-4A06-4E51-9C9C-654A24295EAAQ37668134-76A85527-FB0C-4617-AF62-C6CA14F4355DQ38248776-518CBC72-91CB-4D6F-8956-2C423CA839F8Q38254452-1A7BDA55-BA51-49AE-8555-C2B91050159CQ38343315-95A37FB8-E199-40CA-858E-2B398F395281Q38370198-5115E5A7-DF31-42D3-A3DC-60DA84C63191Q38476909-09E0284A-1859-4534-A608-2BE702050133Q38543238-EDCD06F0-21DC-4DD2-B37D-1A6399B66BF6Q38633125-C6464D9C-2AEB-4B25-BE3E-C421249DFB96Q38659366-E04C66CE-3135-437B-9D08-28FE1BA30633Q38677673-7A5859F5-82D4-489C-8223-07CBD8761CDBQ38692317-A657BF42-379B-428A-AB10-7ABF89A1023DQ38743867-CD829EA7-D923-41DE-8034-FD1282159042
P2860
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review and meta-a ...... of major depressive episodes.
@en
type
label
A systematic review and meta-a ...... of major depressive episodes.
@en
prefLabel
A systematic review and meta-a ...... of major depressive episodes.
@en
P2093
P2860
P50
P1476
A systematic review and meta-a ...... of major depressive episodes.
@en
P2093
P2860
P304
P356
10.1017/S0033291714001603
P407
P577
2014-07-10T00:00:00Z